Concepedia
Statistics
Publications
94
Citations
9K
H-Index
47
Active since
1982
Affiliations
AstraZeneca (Germany)(Current)
AstraZeneca (United States)
Altimmune (United States)
Spirogen (United Kingdom)
SynChem (United States)
Herren Wu is an author at AstraZeneca (Germany) specializing in pharmacy, antibody engineering, and immunology.
Publications per year
1982–2022
Toll-like receptor 9–dependent activation by DNA-containing immune complexes is mediated by HMGB1 and RAGE
Jane Tian, Ana M. Avalos, Su-Yau Mao et al. · Nature Immunology · 2007 · 1.4K citations
Life Sciences, Immunology, Molecular Biology +12
Properties of Human IgG1s Engineered for Enhanced Binding to the Neonatal Fc Receptor (FcRn)
William F. Dall’Acqua, Peter A. Kiener, Herren Wu · Journal of Biological Chemistry · 2006 · 637 citations · Full text
Life Sciences, Immunology, Molecular Biology +15
MEDI-563, a humanized anti–IL-5 receptor α mAb with enhanced antibody-dependent cell-mediated cytotoxicity function
Roland Kolbeck, Alexander Kozhich, Masamichi Koike et al. · Journal of Allergy and Clinical Immunology · 2010 · 578 citations · Full text
Pharmacy, Immunology, Antibody Engineering +8
A Biparatopic HER2-Targeting Antibody-Drug Conjugate Induces Tumor Regression in Primary Models Refractory to or Ineligible for HER2-Targeted Therapy
John Y. Li, Samuel R. Perry, Vanessa Muniz‐Medina et al. · Cancer Cell · 2016 · 390 citations · Full text
Medicine, Oncology, Pharmacology +14
Development of Motavizumab, an Ultra-potent Antibody for the Prevention of Respiratory Syncytial Virus Infection in the Upper and Lower Respiratory Tract
Herren Wu, David S. Pfarr, Syd Johnson et al. · Journal of Molecular Biology · 2007 · 382 citations
Veterinary Medicine, Immunology, Infectious Diseases +16
1–5 of 94